Eisai

Eisai Co Ltd. is a pharmaceutical company that discovers, develops, manufactures, and markets pharmaceuticals, including prescription medicines, OTC drugs, and generics. The company’s franchise areas in research include neurology and oncology. Eisai’s major products include Pariet/AcipHex, a proton pump inhibitor; Aricept, an anti-Alzheimer agent; perampanel, Halaven, an anti-cancer agent; Fycompa tablets for the treatment of epilepsy and peripheral neuropathy. Eisai has production plants in Japan, the UK, China, and India and laboratories in Japan, the US, and the UK; operations in the Americas, Asia, Latin America, EMEA, and Oceania.